SEC Form 4 · accession 0001179110-16-022652
Egalet Corp · EGLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey M. Dayno
Officer — Chief Medical Officer
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2016 | S | 536 | $6.72 | D | 20,356 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on August 6, 2014